Answers are grounded in this paper and cite their sources.
Early-stage chronic kidney disease (CKD) is associated with metabolic alterations that may vary across disease stages, yet metabolic differences between adjacent stages remain insufficiently characterized. This study aimed to delineate urinary metabolic profiles across CKD stages G1–G3B, identify stage-associated metabolic differences, and quantify changes in metabolite concentrations between adjacent stages. High-resolution proton nuclear magnetic resonance (¹H NMR) metabolomics was performed on urine samples from 107 participants.
No takes yet. Share an insight, caveat, or question.
Gupta et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: